Cardiac Valve Market Size, Share & Trends Analysis Report By Treatment (Cardiac Wall Repair, Cardiac Wall Replacement, Others), By Type (Mechanical Valves, Tissue/Bioprosthetic Valves, Transcatheter Heart Valves/Percutaneous Heart Valves, Others), By Valve Position (Mitral Valve, Aortic Valve, Other Position), By End-User (Hospital and Clinics, Specialty Centers, Cardiac Research Institute, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Cardiac Valve Market Size

The global cardiac valve market size was valued at USD 8.65 billion in 2025 and is projected to grow from USD 9.20 billion in 2026 to USD 15.12 billion by 2034, registering a CAGR of 6.4% during the forecast period from 2026 to 2034. North America dominated the cardiac valve market with a market share of 39.2% in 2025.

The rising prevalence of heart disease, combined with an aging population, has resulted in increased demand for cardiac valve replacement and repair procedures. Moreover, advances in medical technology, such as the development of transcatheter aortic valve replacement (TAVR) and minimally invasive surgical techniques, have increased the accessibility and effectiveness of cardiac valve procedures.

The cardiac valve is a crucial component of the cardiovascular system, playing an essential role in maintaining optimal blood flow within the heart's chambers. This specialized valve acts as a meticulous regulator, ensuring precise management of blood circulation. When a natural heart valve becomes damaged or dysfunctional, a cardiac valve replacement procedure becomes necessary to restore normal heart function. The replacement valve is designed as a unidirectional device equipped with sophisticated features that effectively control the direction and pressure of blood flow. This ensures that blood circulates efficiently and reaches all areas of the body that require oxygen and nutrients.

treatment Analysis

The global market is divided into cardiac wall repair, cardiac wall replacement, and others. The cardiac wall repair segment is the leading contributor to market share and is expected to grow significantly during the forecast period. This segment focuses on repairing or reconstructing the heart's damaged or structurally abnormal walls, encompassing a range of devices and procedures tailored for this purpose. Key conditions addressed include ventricular septal defects, atrial septal defects, and various forms of wall damage.

Moreover, innovative methodologies, protocols, and apparatuses are continuously being developed to address structural irregularities within the cardiac walls. These advancements provide effective treatment alternatives, enhancing cardiac function and overall cardiovascular well-being. The ongoing progress and increasing adoption of cardiac wall repair techniques are major drivers of the segment's notable growth.

Request Customizationto receive a tailored report.

type Analysis

The global market is divided into mechanical valves, tissue/bioprosthetic valves, transcatheter heart valves/percutaneous heart valves, and others. The tissue/bioprosthetic valves segment holds the largest market share and is anticipated to grow significantly during the forecast period. These valves, made from animal tissue such as cows or pigs, are chemically treated to be suitable for implantation. Tissue valves are favored for patients who cannot tolerate long-term anticoagulation therapy, as they do not require lifelong blood-thinning medications like mechanical valves. They offer excellent hemodynamic performance and have a lower risk of thromboembolic events. However, tissue valves have a shorter lifespan compared to mechanical valves and may eventually need replacement. The growing preference for tissue valves, driven by their advantages in patient compatibility and safety, is fueling their market expansion.

Valve Position Insights

The global market is divided into mitral valve, aortic valve, and other positions. The mitral valve segment dominates the global market and is expected to grow substantially over the forecast period. This growth is driven by the rising incidence of cardiovascular diseases, influenced by factors such as smoking, obesity, sedentary lifestyles, and stress. The increased prevalence of these risk factors has heightened the demand for mitral valve replacements. The mitral valve plays a crucial role in maintaining optimal blood circulation within the heart, making its proper function vital for cardiovascular health. Consequently, the market for mitral valves has expanded significantly, offering efficient treatment options for patients with cardiovascular conditions.

end-User Analysis

The global market is divided into hospitals and clinics, specialty centers, cardiac research institutes, and others. The hospital and clinics segment holds the largest market share and is expected to grow substantially during the forecast period. This growth is driven by increased government investment, a rise in hospital procedures, and improved cardiovascular disease management. Enhanced funding has facilitated the expansion of hospitals and clinics, allowing them to offer advanced cardiac valve procedures. The growing number of valve replacements and repairs performed in hospitals has further bolstered the segment's dominance. Moreover, the emergence of specialized cardiac care clinics has significantly contributed to market growth. These factors, along with advancements in cardiac care technologies, have positioned the hospital and clinics segment prominently within the industry.

Speak to an Analystto discuss market opportunities.

Regional Insights

Based on region, the global cardiac valve market share is bifurcated into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

North America Dominates the Global Market

North America holds the largest market share globally and is expected to expand substantially during the forecast period.This growth is driven by the high prevalence of cardiovascular diseases, a well-established healthcare infrastructure, and the presence of major market players. According to the American Heart Association, cardiovascular diseases accounted for approximately 877,500 deaths in the United States in 2023, underscoring the significant burden of these conditions and the consequent demand for advanced cardiac valve products. The Centers for Disease Control and Prevention report that over 91,000 inpatient valve procedures were performed in the United States in 2022, with this number expected to reach 97,000 by 2024, reflecting the increasing need for cardiac valve interventions.

North America's well-developed healthcare system, featuring advanced diagnostic and treatment facilities, has facilitated the early detection and management of cardiac valve disorders, driving the adoption of innovative cardiac valve products. For instance, the Cleveland Clinic, renowned for its cardiovascular care, routinely performs cutting-edge valve replacement surgeries. Moreover, the presence of major market players such as Edwards Lifesciences, Medtronic, and Abbott Laboratories, coupled with their significant investments in research and development, has solidified North America's dominance in the cardiac valve market. These companies continuously introduce new and advanced products, such as Edwards Lifesciences' Sapien 3 Ultra valve and Medtronic's Evolut PRO+ TAVR system, catering to the diverse needs of patients and healthcare providers in the region.

Unlock Regional Insightsto access country-level data, & regional trends.

List of Key and Emerging Players in Cardiac Valve Market